• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Partnerships

Our partners

Home > Partnerships

Our partners

  • Our partners
  • Partnering with us

Collaboration is an essential part of DNDi’s virtual R&D model: we cannot carry out our work without the engagement of public and private partners.

Today, DNDi has forged a diverse range of alliances and research collaborations with over 200 partners and service providers in nearly 50 countries.

Industry partners and service providers
Universities and research centres
Non-profit organizations, NGOs, and networks
Healthcare providers
Ministries of health and governments

Non-profit organizations, NGOs, and networks

Loading…
Alliance for International Medical Action (ALIMA)

France / Senegal

Loading…
ANTICOV /
Loading…
test image
AMPATH

Kenya

Loading…
Loading…
Paediatric HIV /
test image
Aurum Institute NPC

South Africa

Loading…
Immediate-release flucytosine & liposomal amphotericin B access /
Loading…
test image
AWOL

UK

Loading…
Flubentylosin /
Loading…
test image
Casa de Chagas, Pernambuco

Brazil

Loading…
Chagas Access Project /
Chagas Platform /
Loading…
test image
Chagas Disease Global Coalition

Spain

Loading…
Chagas Access Project /
Chagas Platform /
Loading…
test image
Clinton Health Access Initiative (CHAI)

USA

Loading…
2-in-1 LPV/r pellets and ABC/3TC or AZT/3TC /
Immediate-release flucytosine & liposomal amphotericin B access /
Loading…
test image
Collective of Applied Studies and Social Development (CEADES)

Bolivia

Loading…
Azoles E1224 /
Chagas Platform /
Fexinidazole for Chagas /
New benznidazole regimens /
Loading…
test image
Communauté Baptiste du Congo (CBCO)

DRC

Loading…
Fexinidazole for T.b. gambiense /
Loading…
test image
Cryptococcal Meningitis Action Group (CryptoMAG)

International

Loading…
Immediate-release flucytosine & liposomal amphotericin B access /
Loading…
test image
Diamond Light Source

UK

Loading…
ASAP-0017445 (Moonshot ASAP) /
AViDD ASAP /
COVID Moonshot /
Loading…
test image
Eastern Africa Network for Trypanosomosis (EANETT)
Loading…
HAT Platform /
Loading…
test image
Elizabeth Glaser Pediatric AIDS Foundation

USA

Loading…
4-in-1 (ABC/3TC/LPV/r) /
Loading…
Paediatric HIV /
test image
Enhancing Care Foundation

South Africa

Loading…
Super-booster therapy /
Loading…
test image
Epicentre (MSF) – France

France

Loading…
2-in-1 LPV/r pellets and ABC/3TC or AZT/3TC /
ACOZI-KIDS /
Acoziborole /
ANTICOV /
ASAQ /
ASMQ /
Fexinidazole for T.b. rhodesiense /
LeishAccess /
Nifurtimox-eflornithine combination therapy (NECT) /
Loading…
test image
Epicentre (MSF) – Uganda

Uganda

Loading…
2-in-1 LPV/r pellets and ABC/3TC or AZT/3TC /
4-in-1 (ABC/3TC/LPV/r) /
Loading…
test image
European Agency for Development and Health (AEDES)

Belgium

Loading…
ASAQ /
Loading…
test image
Family AIDS Care and Education Services (FACES) Project

Kenya

Loading…
2-in-1 LPV/r pellets and ABC/3TC or AZT/3TC /
Loading…
test image
FIND, the global alliance for diagnostics

Switzerland

Loading…
AfriKADIA /
ANTICOV /
Chagas Access Project /
Chagas Platform /
HAT Platform /
Hepatitis C PACT /
Hepatitis C Screening in Malaysia – #MYmissingmillions /
LEAP Platform /
LeishAccess /
Ravidasvir + sofosbuvir /
Loading…
test image
Fiotec

Brazil

Loading…
Miltefosine + thermotherapy for cutaneous leishmaniasis /
Loading…
test image
Foundation for Neglected Disease Research

India

Loading…
Loading…
Pandemic Preparedness /
test image
Foundation for the National Institutes of Health (FNIH)

USA

Loading…
Loading…
Sleeping sickness /
test image
Fundação de Medicina Tropical Heitor Vieira Dourado

Brazil

Loading…
LXE408 Novartis for CL /
redeLEISH Network /
Loading…
test image
Fundación Huésped

Argentina

Loading…
New benznidazole regimens /
Loading…
test image
Fundación MEDINA

Spain

Loading…
Screening Chagas disease /
Screening leishmaniasis /
Loading…
Chagas disease /
Visceral leishmaniasis /
test image
Fundación Mundo Sano

Argentina

Loading…
Biomarkers /
Chagas Access Project /
Chagas Platform /
New benznidazole regimens /
Paediatric Benznidazole /
Ravidasvir + sofosbuvir /
Loading…
test image
Fundación SANIT

Bolivia

Loading…
Chagas Access Project /
Loading…
test image
FUNDERMA – Fundación Nacional de Dermatología

Bolivia

Loading…
Miltefosine + thermotherapy for cutaneous leishmaniasis /
redeLEISH Network /
Loading…
test image
Global Institute for Disease Elimination (GLIDE)

United Arab Emirates

Loading…
Loading…
test image
HAT Platform
Loading…
Acoziborole /
Fexinidazole for T.b. gambiense /
Nifurtimox-eflornithine combination therapy (NECT) /
Loading…
test image
i-Base

UK

Loading…
Loading…
Paediatric HIV /
test image
IDA Foundation

The Netherlands

Loading…
SSG&PM (East Africa) /
Loading…
test image
International Community of Women Living with HIV

Kenya

Loading…
Loading…
Paediatric HIV /
test image
Leishmaniasis East Africa Platform (LEAP)
Loading…
Fexinidazole/Miltefosine Combination (VL) /
Miltefosine + Paromomycin combination (Africa) /
New treatments for PKDL (Eastern Africa) /
New treatments for VL/HIV /
SSG&PM (East Africa) /
VL-0208 /
Loading…
test image
Lilongwe Medical Relief Fund Trust (UNC Project – Malawi)

Malawi

Loading…
5FC HIV-Crypto /
Loading…
test image
Malaysian AIDS Council (MAC)

Malaysia

Loading…
Ravidasvir + sofosbuvir /
Loading…
test image
Management and Development for Health (MDH)

Tanzania

Loading…
2-in-1 LPV/r pellets and ABC/3TC or AZT/3TC /
Loading…
test image
Médecins Sans Frontières (MSF)

International

Loading…
4-in-1 (ABC/3TC/LPV/r) /
ASAQ /
Biomarkers /
Chagas Platform /
Fexinidazole for T.b. gambiense /
Generic AmBisome /
HAT Platform /
Hepatitis C PACT /
LEAP Platform /
New treatments for VL/HIV /
Loading…
test image
Médecins Sans Frontières (MSF) – Artsen zonder Grenzen

The Netherlands

Loading…
LeishAccess /
Miltefosine + Paromomycin combination (Africa) /
SSG&PM (East Africa) /
VL-INNO /
Loading…
test image
Médecins Sans Frontières (MSF) Bolivia

Bolivia

Loading…
Chagas Access Project /
Loading…
test image
Médecins Sans Frontières (MSF) France

France

Loading…
Ravidasvir + sofosbuvir /
Loading…
test image
Médecins sans Frontières (MSF) Japan

Japan

Loading…
Loading…
test image
Médecins Sans Frontières (MSF) México

Mexico

Loading…
Chagas Access Project /
Loading…
test image
Médecins Sans Frontières (MSF) Spain

Spain

Loading…
Chagas Access Project /
New VL treatments (South Asia) /
Loading…
test image
Médecins Sans Frontières (MSF) Switzerland

Switzerland

Loading…
Miltefosine + Paromomycin combination (Africa) /
SSG&PM (East Africa) /
Loading…
test image
Médecins Sans Frontières (MSF) Ukraine

Ukraine

Loading…
Loading…
test image
Medicines Development for Global Health

Australia

Loading…
Emodepside /
Loading…
test image
Medicines for Malaria Venture (MMV)

Switzerland

Loading…
ANTICOV /
ASAQ /
ASMQ /
DNDi Screening of the MMV Open Access Malaria Box for HAT, VL, and Chagas disease /
Guides to free computational chemistry tools for drug discovery /
Hit-to-lead broad-spectrum antivirals /
Pandemic Response Box /
Pathogen Box /
Screening Chagas disease /
Screening Filarial disease /
Loading…
test image
Médicos Sem Fronteiras (MSF) Brasil

Brazil

Loading…
Chagas Access Project /
Loading…
test image
MSF Access Campaign

International

Loading…
Immediate-release flucytosine & liposomal amphotericin B access /
Loading…
test image
National Institute of Pharmaceutical Education and Research, Hajipur

India

Loading…
Open Synthesis Network /
Loading…
test image
NEPHAK

Kenya

Loading…
Loading…
Paediatric HIV /
test image
NHEPACHA network

USA

Loading…
Biomarkers /
Loading…
test image
OneWorld Health (OWH)

USA

Loading…
New VL treatments (South Asia) /
Loading…
test image
Pan American Health Organization (PAHO)
Loading…
Chagas Access Project /
Chagas Platform /
redeLEISH Network /
Loading…
test image
Pan American Health Organization (PAHO) Bolivia

Bolivia

Loading…
Chagas Access Project /
Loading…
test image
Pan American Health Organization (PAHO) Colombia

Colombia

Loading…
Chagas Access Project /
Loading…
test image
PATH

USA

Loading…
New VL treatments (South Asia) /
Loading…
test image
Platform of Integral Care for Patients with Chagas Disease, Tarija and Cochabamba

Bolivia

Loading…
Fexinidazole for Chagas /
Loading…
test image
Platforms of Integral Care for Patients with Chagas Disease

Bolivia

Loading…
Azoles E1224 /
New benznidazole regimens /
Loading…
test image
Public Health Foundation of India

India

Loading…
Loading…
test image
Royal Society of Chemistry

United Kingdom

Loading…
Loading…
test image
Salvensis

UK

Loading…
Screening Filarial disease /
Loading…
test image
Seattle Structural Genomics Center for Infectious Disease (SSGCID)

USA

Loading…
Loading…
Chagas disease /
Cutaneous leishmaniasis /
Visceral leishmaniasis /
test image
Structural Genomics Consortium (SGC)
Loading…
Loading…
Chagas disease /
Cutaneous leishmaniasis /
Visceral leishmaniasis /
test image
TB Alliance

USA

Loading…
DNDI-0690 /
Guides to free computational chemistry tools for drug discovery /
Nitroimidazole (Chagas) /
Screening Chagas disease /
Screening leishmaniasis /
SCYX-2035811 /
VL-2098 /
Loading…
test image
The International Federation of Associations of People Affected by Chagas disease (FINDECHAGAS Brazil)

Brazil

Loading…
Chagas Access Project /
Chagas Platform /
Loading…
test image
The International Federation of Associations of People Affected by Chagas disease (FINDECHAGAS Colombia)

Colombia

Loading…
Chagas Access Project /
Loading…
test image
The Task Force for Global Health

USA

Loading…
Loading…
Filaria: river blindness /
test image
Top Institute Pharma (TI Pharma)

The Netherlands

Loading…
Loading…
Sleeping sickness /
Visceral leishmaniasis /
test image
Unitaid

Switzerland

Loading…
2-in-1 LPV/r pellets and ABC/3TC or AZT/3TC /
Immediate-release flucytosine & liposomal amphotericin B access /
Loading…
Paediatric HIV /
test image
UNITE, The Global Parliamentarians Network to End Infectious Diseases

International

Loading…
Loading…
Paediatric HIV /
test image
Uniting to Combat NTDs

United Kingdom

Loading…
Loading…
test image
WHO-TDR, Special Programme for Research and Training in Tropical Diseases

Switzerland

Loading…
ASAQ /
ASMQ /
New VL treatments (South Asia) /
redeLEISH Network /
Screening Chagas disease /
Screening leishmaniasis /
Loading…
test image
WomenLift Health

India

Loading…
Loading…
test image
World Health Organization (WHO)

Switzerland

Loading…
Chagas Platform /
Fexinidazole for T.b. gambiense /
Fexinidazole for T.b. rhodesiense /
HAT Platform /
LEAP Platform /
Nifurtimox-eflornithine combination therapy (NECT) /
Screening Chagas disease /
Screening leishmaniasis /
Loading…
Chagas disease /
test image
World Health Organization (WHO) India

India

Loading…
New treatments for PKDL (South Asia) /
Loading…
test image
World Health Organization (WHO) Regional Office for Africa

Republic of Congo

Loading…
Fexinidazole for T.b. gambiense /
Loading…
test image
World Health Organization (WHO) South-East Asia

India

Loading…
New treatments for PKDL (South Asia) /
Loading…
test image
Worldwide Antimalarial Resistance Network (WWARN)

International

Loading…
ASMQ /
Loading…
test image

Become a partner

Help us bring the best science to the most neglected.

contact us
Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License